Evidence map›Paper›PMID 27716399›Full record

Observational studyArthritis research & therapy2016

Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet's disease: a retrospective observational study.

Yohei Kirino, Haruko Ideguchi, Mitsuhiro Takeno, Akiko Suda, Kana Higashitani, Yosuke Kunishita, Kaoru Takase-Minegishi, Maasa Tamura, Toshiyuki Watanabe, Yukiko Asami and 11 more

Open access · goldAbstract readObservational Study
In one paragraph

Observational study in Arthritis research & therapy, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Behçet's Disease: A Comprehensive Review on the Role ofInternational journal of molecular sciences · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Observational
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Update on the Diagnosis of Behçet's Disease.Diagnostics (Basel, Switzerland) · 2022
    Review
  17. Global epidemiology of vasculitis.Nature reviews. Rheumatology · 2022
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 1 country.

Yohei KirinoDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan. Kirino@yokohama-cu.ac.jp.ORCID 0000-0002-9488-661X
Haruko IdeguchiDepartment of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
Mitsuhiro TakenoDepartment of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo, Japan.
Akiko SudaYokosuka Center for Rheumatic Diseases, Yokosuka City Hospital, Yokosuka, Japan.
Kana HigashitaniDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Yosuke KunishitaDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Kaoru Takase-MinegishiCenter for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan.
Maasa TamuraDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Toshiyuki WatanabeDepartment of Rheumatology, National Hospital Organization Yokohama Medical Center, Yokohama, Japan.
Yukiko AsamiDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Takeaki UeharaDepartment of Rheumatology, Chigasaki City Hospital, Chigasaki, Japan.
Ryusuke YoshimiDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Tetsu YamazakiDepartment of Rheumatology, Yamato City Hospital, Yamato, Japan.
Akiko SekiguchiDepartment of Hematology and Rheumatology, Fujisawa City Hospital, Fujisawa, Japan.
Atsushi IhataDepartment of Rheumatology, National Hospital Organization Yokohama Medical Center, Yokohama, Japan.
Shigeru OhnoCenter for Rheumatic Diseases, Yokohama City University Medical Center, Yokohama, Japan.
Atsuhisa UedaDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Toshihisa IgarashiDepartment of Rheumatology, Yamato City Hospital, Yamato, Japan.
Shohei NagaokaDepartment of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan.
Yoshiaki IshigatsuboYokohama City University, Yokohama, Japan.
Hideaki NakajimaDepartment of Stem Cell and Immune Regulation, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-Ku, Yokohama, 236-0004, Japan.
Yokohama City University · JPNational Hospital Organization · JPYamato Municipal Hospital · JPYokohama City University Medical Center · JPYokohama Minami Kyosai Hospital · JPChigasaki Rehabilitation College · JPFujisawa City Hospital · JPHiratsuka City Hospital · JPNippon Medical School · JPYokohama University of Pharmacy · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIt has been suggested that the phenotypes of Behçet's disease (BD) in Japan are changing. To ask whether the evolution of BD holds true in recent-onset cases in Japan, we performed a retrospective study.

methodsWe reviewed the records of 578 patients with BD who met the 1987 revised diagnostic criteria of the Behçet's disease research committee of Japan. The patients were divided into three groups based on the date of disease onset. We compared the demography, clinical features, and treatments among them with or without adjustment for the observation period. Patients having oral ulcers, genital ulcers, regional skin involvement, and uveitis are categorized as having complete-type BD, and the associated factors were determined by univariate and multivariate logistic regression analyses.

resultsMale patients had a higher propensity for uveitis and central nervous system (CNS) involvement, whereas female patients had higher rates of genital ulcers and arthritis. We found a significant trend in reduction of complete-type, genital ulcer, HLA-B51 carriers, and increment of gastrointestinal BD over time. Multiple regression analysis identified HLA-B51 positivity, earlier date of disease onset, and younger age of onset as independently associated with complete-type BD. Although treatments had been also chronologically changed, the causative relationship between therapeutic agents and phenotypical changes was not determined from the study.

conclusionThe present study revealed that phenotypical evolution was characterized by decreased incidence of the complete type and increment of gastrointestinal involvement in Japanese patients with BD during the last 30 years.

Indexed as

AdultAsian PeopleBehcet SyndromeFemaleHumansMaleMiddle AgedPhenotypeRetrospective StudiesBehçet’s diseaseComplete typeEvolutionHLA-B51

Identifiers

PMID27716399
PMCPMC5048408
OpenAlexW2528677717

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.